Lifetime risk, life expectancy, and years of life lost to type 2 diabetes in 23 high-income jurisdictions: a multinational, population-based study

Using data from 24 population-based data sources from Europe, Asia, North America, and Oceania, we estimated the lifetime risk of type 2 diabetes, life expectancy in people with and without type 2 diabetes, and years of life lost to type 2 diabetes. With the incidence of type 2 diabetes declining in the high-income setting, there has been a corresponding decrease in lifetime risk in many high-income jurisdictions.

However, the burden of diabetes remains high. This substantial individual burden should be considered in future public health strategy and emphasised in patient counselling to improve health outcomes for people with type 2 diabetes.

THE LANCET Diabetes and Endocrinology VOLUME 10, ISSUE 11, NOVEMBER 01, 2022